Deals
Period Tracker Flo Gets $200 Million Investment to Expand to Menopause
- UK-based startup to increase headcount and expand its offering
- Flo has built an enormous trove of women’s health data
The London-based company will use the investment to increase headcount and expand its offering to cater to women experiencing menopause.
Source: Flo HealthThis article is for subscribers only.
Flo Health Inc., a period and fertility tracking app, has raised $200 million from private equity firm General Atlantic, as historically overlooked women’s health issues gain more investor attention.
The London-based company, which has 68 million monthly active users and about five million paying subscribers, will use the investment to increase headcount and expand its offering to cater to women experiencing menopause, the company said on Tuesday. The funding round, which will complete in the coming weeks, values Flo at more than $1 billion, the company said.